Harnessing the Therapeutic Potential of Antimicrobial Peptides for Cancers: State of the Art

Author:

Mahjoubin-Tehran Maryam12,Rezaei Samaneh12,Aghaee-Bakhtiari Seyed Hamid12,Sahebkar Amirhossein3456,Oskuee Reza Kazemi137,Mahmoudi Ali12,Jalili Amin2

Affiliation:

1. Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

2. Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

4. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

5. School of Medicine, The University of Western Australia, Perth, Australia

6. Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

7. Targeted Drug Delivery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract

Abstract: Despite significant breakthroughs in cancer treatment, cancer remains a serious global health concern that takes thousands of lives each year. Still, drug resistance and adverse effects are the main problems in conventional cancer therapeutic approaches. Thus, the discovery of new anti-cancer agents with distinct mechanisms of action is a critical requirement that offers significant ob-stacles. Antimicrobial peptides (AMPs), which can be found in various forms of life, are recognized as defensive weapons against infections of microbial pathogens. Surprisingly, they are also capable of killing a variety of cancer cells. These powerful peptides can cause cell death in the gastrointesti-nal, urinary tract, and reproductive cancer cell lines. To emphasize the anti-cancer properties of AMPs, we summarize the research that examined their impact on cancer cell lines in this review.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3